XLO logo

Xilio Therapeutics (XLO) Accounts Receivable

Annual Accounts Receivable

$1.53 M
-$3.13 M-67.26%

December 31, 2023


Summary


Performance

XLO Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXLObalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

XLO Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-67.3%-
3 y3 years-25.7%-
5 y5 years+411.9%-

XLO Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-67.3%+440.7%
5 y5-year-67.3%+440.7%
alltimeall time-67.3%+2321.3%

Xilio Therapeutics Accounts Receivable History

DateAnnualQuarterly
Dec 2023
$1.53 M(-67.3%)
-
Dec 2022
$4.66 M(+1551.4%)
-
Dec 2021
$282.10 K(-86.3%)
-
Dec 2020
$2.05 M(+386.3%)
-
DateAnnualQuarterly
Dec 2019
$422.10 K(+41.6%)
-
Dec 2018
$298.00 K(+234.8%)
-
Dec 2017
$89.00 K(+41.3%)
-
Dec 2016
$63.00 K
-

FAQ

  • What is Xilio Therapeutics annual accounts receivable?
  • What is the all time high annual accounts receivable for Xilio Therapeutics?
  • What is Xilio Therapeutics annual accounts receivable year-on-year change?

What is Xilio Therapeutics annual accounts receivable?

The current annual accounts receivable of XLO is $1.53 M

What is the all time high annual accounts receivable for Xilio Therapeutics?

Xilio Therapeutics all-time high annual accounts receivable is $4.66 M

What is Xilio Therapeutics annual accounts receivable year-on-year change?

Over the past year, XLO annual accounts receivable has changed by -$3.13 M (-67.26%)